43 related articles for article (PubMed ID: 26886341)
21. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
22. Sphingolipids in pulmonary fibrosis.
Huang LS; Natarajan V
Adv Biol Regul; 2015 Jan; 57():55-63. PubMed ID: 25446881
[TBL] [Abstract][Full Text] [Related]
23. Claudins and alveolar epithelial barrier function in the lung.
Frank JA
Ann N Y Acad Sci; 2012 Jun; 1257():175-83. PubMed ID: 22671604
[TBL] [Abstract][Full Text] [Related]
24. Animal models of fibrotic lung disease.
B Moore B; Lawson WE; Oury TD; Sisson TH; Raghavendran K; Hogaboam CM
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):167-79. PubMed ID: 23526222
[TBL] [Abstract][Full Text] [Related]
25. Murine models of pulmonary fibrosis.
Moore BB; Hogaboam CM
Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L152-60. PubMed ID: 17993587
[TBL] [Abstract][Full Text] [Related]
26. In vitro, ex vivo and in vivo methods of lung absorption for inhaled drugs.
Sakagami M
Adv Drug Deliv Rev; 2020; 161-162():63-74. PubMed ID: 32763274
[TBL] [Abstract][Full Text] [Related]
27. Fundamentals of pulmonary drug delivery.
Groneberg DA; Witt C; Wagner U; Chung KF; Fischer A
Respir Med; 2003 Apr; 97(4):382-7. PubMed ID: 12693798
[TBL] [Abstract][Full Text] [Related]
28. Progress toward improving animal models for idiopathic pulmonary fibrosis.
Degryse AL; Lawson WE
Am J Med Sci; 2011 Jun; 341(6):444-9. PubMed ID: 21613932
[TBL] [Abstract][Full Text] [Related]
29. The Witschi Hypothesis revisited after 35 years: genetic proof from SP-C BRICHOS domain mutations.
Uhal BD; Nguyen H
Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(12):L906-11. PubMed ID: 24142519
[TBL] [Abstract][Full Text] [Related]
30. Cell adhesion molecules and pulmonary fibrosis.
Paine R; Ward PA
Am J Med; 1999 Sep; 107(3):268-79. PubMed ID: 10492321
[No Abstract] [Full Text] [Related]
31. In vitro cell culture models for the assessment of pulmonary drug disposition.
Sporty JL; Horálková L; Ehrhardt C
Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):333-45. PubMed ID: 18433340
[TBL] [Abstract][Full Text] [Related]
32. Bleomycin: a pharmacologic tool in the study of the pathogenesis of interstitial pulmonary fibrosis.
Lazo JS; Hoyt DG; Sebti SM; Pitt BR
Pharmacol Ther; 1990; 47(3):347-58. PubMed ID: 1705351
[TBL] [Abstract][Full Text] [Related]
33. Role of Sensory Nerves in Pulmonary Fibrosis.
Norton CE
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542511
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary cell culture models to study the safety and efficacy of innovative aerosol medicines.
Bur M; Lehr CM
Expert Opin Drug Deliv; 2008 Jun; 5(6):641-52. PubMed ID: 18532920
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor-beta induces fibrosis in immune cell-depleted lungs.
Olman MA; Matthay MA
Am J Physiol Lung Cell Mol Physiol; 2003 Sep; 285(3):L522-6. PubMed ID: 12902316
[No Abstract] [Full Text] [Related]
36. Progress in drug delivery system for fibrosis therapy.
Xing L; Chang X; Shen L; Zhang C; Fan Y; Cho C; Zhang Z; Jiang H
Asian J Pharm Sci; 2021 Jan; 16(1):47-61. PubMed ID: 33613729
[TBL] [Abstract][Full Text] [Related]
37. Alteration in Intrapulmonary Pharmacokinetics of Aerosolized Model Compounds Due to Disruption of the Alveolar Epithelial Barriers Following Bleomycin-Induced Pulmonary Fibrosis in Rats.
Togami K; Chono S; Tada H
J Pharm Sci; 2016 Mar; 105(3):1327-34. PubMed ID: 26886341
[TBL] [Abstract][Full Text] [Related]
38. [Intrapulmonary Pharmacokinetics and Drug Distribution Characteristics for the Treatment of Respiratory Diseases].
Togami K
Yakugaku Zasshi; 2020; 140(3):345-354. PubMed ID: 32115551
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
